medical equipment posts

Feed

Is a Bottom in Place with Becton?

Just call it a 'June Swoon' for Becton Dickinson and Co. (BDX), as the shares have dropped to about $69.50 from highs above $80 this spring. Even so, the business model, first discussed here on March 17, 2009 at a price of $65.66, remains preferred in these circles. Here's why:

In FY2010 Becton's revenue growth should total about 5-7%, after essentially flat revenue in FY2009. Hospital spending cutbacks will hurt, but BDX should make up for that with increased government orders, lower operating costs, and moderating raw material costs. Becton's medical and diagnostic units will also likely register revenue growth at or above 5-6% in 2010; its bioscience unit will register more-modest gains.

Continue reading Is a Bottom in Place with Becton?

Top Picks for 2010: Becton, Dickinson (BDX)

This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.

"Medical equipment giant Becton, Dickinson and Co. (BDX) is our top investment pick for the coming year," says Jonas Elmerraji. Here's his review from the advisor's Rhino Stock Report.

"If anything's certain for 2010, it'll be that nothing's certain as far as stocks are concerned. With a substantial rally that's pushed the valuations of major indexes like the S&P 500 and Dow more than 60% higher since mid-March lows, it's inevitable for investor anxiety to spill over into the New Year.

Continue reading Top Picks for 2010: Becton, Dickinson (BDX)

Sideways stock movement likely over for Becton Dickinson

Medical equipment giant Becton Dickinson's (NYSE: BDX) stock has meandered since recommended on March 17, 2009 at a price of $65.66, with volatility, most likely due to U.S. federal health care reform legislation uncertainty, but look for better quarters ahead, when the dust settles, which is why I'm reiterating my Buy rating for the company's shares.

In FY2010, Becton's revenue growth should total about 5-7%, after essentially flat revenue in FY2009. Hospital spending cutbacks will hurt, but BDX will make up for the aforementioned with increased government orders, lower operating costs, and moderating raw material costs.

Continue reading Sideways stock movement likely over for Becton Dickinson

Symbol Lookup
IndexesChangePrice
DJIA-74.9212,454.83
NASDAQ-1.852,837.53
S&P 500-2.861,317.82

Last updated: May 28, 2012: 12:05 PM

Hot Stocks

General Electric

19.20-0.05(-0.26)

Alcoa

8.630.00(0.00)

Apple Inc

562.29-3.03(-0.54)

Google Inc 'A'

591.53-12.13(-2.01)

Bank of America

7.15+0.01(+0.14)

Wal-Mart Stores

65.31+0.24(+0.37)

Exxon Mobil Corp

82.08-0.53(-0.64)

Ford

10.60+0.01(+0.09)

Citigroup

26.47-0.19(-0.71)

IBM

194.30-1.79(-0.91)

Yahoo

15.36+0.01(+0.07)

Starbucks

54.56-0.20(-0.37)

Microsoft

29.06-0.01(-0.03)

Home Depot

49.44-0.27(-0.54)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1338221138820 ms.